Skip to the page

Data / Drug companies / Sandoz Inc

Sandoz Inc: 327 products in the FDA NDC directory, labeler code 0781

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Sandoz Inc (labeler code 0781) lists 327 products in the FDA National Drug Code Directory, covering 115 finished drugs by generic name. By type: 323 prescription drugs, 3 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 12, 2026.

The request: Watch Sandoz Inc (FDA labeler code 0781): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0781
Products in commercial distribution
327
Packages
464
Finished drugs by generic name
115
Prescription products
323
Over the counter products
3
Controlled substance products
Schedule II 29, Schedule III 1, Schedule IV 12
Flagged as original packager
291 of 291 products that carry the flag
Started marketing in the last 12 months
35
Products with a marketing end date set
22
Earliest marketing start
March 3, 1971
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)25477.7%
Authorized generics (NDA)5918%
New drug applications (NDA)103.1%
Biologics (BLA)30.9%
Drugs for further processing10.3%

Products by type

TypeProductsShare
Prescription drugs32398.8%
Over the counter drugs30.9%
Drugs for further processing10.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Ampicillin sodium2011
Estradiol1153
Heparin sodium923
Methylphenidate85
Dexmethylphenidate hydrochloride817
Amoxicillin835
Amoxicillin and clavulanate potassium735
Enoxaparin sodium718
Enoxaparin sodium injection,usp71
Lisdexamfetamine dimesylate716
Carbidopa, levodopa, and entacapone61
Amitriptyline hydrochloride635
Cyclophosphamide622
Phenylephrine hydrochloride677
Omeprazole5106
Piperacillin and tazobactam513
Ceftriaxone sodium512
Alprazolam437
Oxaliplatin416
Perphenazine418
Clarithromycin427
Pomalidomide412
Treprostinil46
Fondaparinux sodium46
Glycopyrrolate464
Armodafinil412
Aprepitant47
Zolpidem tartrate438
Trifluoperazine hydrochloride46
Isosorbide dinitrate318
Cisatracurium besylate315
Iron sucrose35
Bumetanide342
Pirfenidone326
Clindamycin in 5 percent dextrose33
Cefazolin311
Sitagliptin phosphate31
Azithromycin341
Dexmedetomidine hydrochloride in 0.9% sodium chloride34
Tacrolimus335
Pemetrexed disodium314
Voriconazole334
Rivastigmine311
Somatropin36
Cetirizine hydrochloride3119
Meropenem217
Acetaminophen2214
Lidocaine hydrochloride2134
Caspofungin acetate27
Linezolid228
Fulvestrant221
Sugammadex222
Mycophenolate mofetil237
Sitagliptin and metformin hydrochloride28
Succinylcholine chloride227
Nintedanib211
Dapagliflozin226
Prucalopride218
Olanzapine249
Cefpodoxime proxetil211
Mesalamine241
Glatiramer acetate28
Ultramicrosize griseofulvin24
Chlorpromazine hydrochloride227
Griseofulvin26
Penicillin g potassium28
Triamterene and hydrochlorothiazide127
Cosyntropin14
Norepinephrine bitartrate125
Bromocriptine mesylate19
Fluorometholone14
Fluvastatin sodium14
Cefdinir125
Butalbital, aspirin, and caffeine15
Rocuronium bromide125
Difluprednate ophthalmic15
Brinzolamide16
Albuterol sulfate146
Ampicillin110
Tigecycline16
Paclitaxel120
Brimonidine tartrate and timolol maleate114
Arsenic trioxide121
Sevoflurane19
Bimatoprost115
Ciprofloxacin hydrochloride and hydrocortisone15
Cladribine17
Ferumoxytol13
Carmustine113
Edaravone14
Estradiol valerate and estradiol valerate/dienogest12
Fidaxomicin16
Tafluprost14
Ciprofloxacin and dexamethasone112
Leuprolide acetate116
Tamsulosin hydrochloride138
Digoxin133
Ephedrine sulfate126
Palonosetron hydrochloride111
Eribulin mesylate117

Dosage forms

Dosage formProductsShare
Tablet, film coated4814.7%
Injection, solution4714.4%
Injection4313.1%
Injection, powder, for solution3711.3%
Capsule288.6%
Capsule, extended release247.3%
Tablet216.4%
Injection, powder, lyophilized, for solution123.7%
Patch, extended release82.4%
Kit72.1%
Powder, for suspension61.8%
Patch61.8%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Lidocaine hydrochloride0781-3539Injection, solutionGeneric drugs (ANDA)October 12, 2026
Lidocaine hydrochloride0781-3537Injection, solutionGeneric drugs (ANDA)October 12, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2734Capsule, extended releaseAuthorized generics (NDA)October 1, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2733Capsule, extended releaseAuthorized generics (NDA)October 1, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2732Capsule, extended releaseAuthorized generics (NDA)October 1, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2731Capsule, extended releaseAuthorized generics (NDA)October 1, 2026
Bumetanide0781-8160TabletGeneric drugs (ANDA)September 28, 2026
Bumetanide0781-8113TabletGeneric drugs (ANDA)September 28, 2026
Bumetanide0781-8099TabletGeneric drugs (ANDA)September 28, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2730Capsule, extended releaseAuthorized generics (NDA)September 24, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2729Capsule, extended releaseAuthorized generics (NDA)September 24, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2728Capsule, extended releaseAuthorized generics (NDA)September 24, 2026
Dexmethylphenidate Hydrochloride Extended-Release0781-2727Capsule, extended releaseAuthorized generics (NDA)September 24, 2026
Pomalidomide0781-2369CapsuleGeneric drugs (ANDA)September 1, 2026
Pomalidomide0781-2366CapsuleGeneric drugs (ANDA)September 1, 2026
Pomalidomide0781-2358CapsuleGeneric drugs (ANDA)September 1, 2026
Pomalidomide0781-2354CapsuleGeneric drugs (ANDA)September 1, 2026
Fidaxomicin0781-5194Tablet, film coatedGeneric drugs (ANDA)August 27, 2026
Sugammadex0781-3469Injection, solutionGeneric drugs (ANDA)July 28, 2026
Sugammadex0781-3468Injection, solutionGeneric drugs (ANDA)July 28, 2026
Mesalamine0781-2791Capsule, extended releaseGeneric drugs (ANDA)July 21, 2026
Mesalamine0781-2793Capsule, extended releaseGeneric drugs (ANDA)July 15, 2026
Ferric Carboxymaltose0781-3542Injection, solutionAuthorized generics (NDA)July 3, 2026
Sitagliptin and Metformin Hydrochloride0781-5802Tablet, film coatedGeneric drugs (ANDA)May 28, 2026
Sitagliptin and Metformin Hydrochloride0781-5801Tablet, film coatedGeneric drugs (ANDA)May 28, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.